Article
Cash-rich BioNTech broadens scope as COVID shot sales slide
Rating:
0.0
Views:
41
Likes:
1
Library:
1
Germany's BioNTech , Pfizer's partner on COVID-19 vaccines, said on Monday its first-quarter net income plunged on lower demand for the shots as it widens its work on cancer and other diseases.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value